349 related articles for article (PubMed ID: 19262519)
1. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
2. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
[TBL] [Abstract][Full Text] [Related]
3. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
4. Serum adiponectin in chronic hepatitis C and B.
Siagris D; Vafiadis G; Michalaki M; Lekkou A; Starakis I; Makri M; Margaritis V; Christofidou M; Tsamandas AC; Labropoulou-Karatza C
J Viral Hepat; 2007 Aug; 14(8):577-83. PubMed ID: 17650292
[TBL] [Abstract][Full Text] [Related]
5. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
Poustchi H; Negro F; Hui J; Cua IH; Brandt LR; Kench JG; George J
J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
[TBL] [Abstract][Full Text] [Related]
7. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
9. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
10. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A
Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
[TBL] [Abstract][Full Text] [Related]
11. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
Hepatogastroenterology; 2007; 54(75):854-7. PubMed ID: 17591078
[TBL] [Abstract][Full Text] [Related]
12. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
[TBL] [Abstract][Full Text] [Related]
14. Low density lipoprotein receptor transcripts correlates with liver hepatitis C virus RNA in patients with alcohol consumption.
Carrière M; Rosenberg AR; Conti F; Chouzenoux S; Terris B; Sogni P; Soubrane O; Calmus Y; Podevin P
J Viral Hepat; 2006 Sep; 13(9):633-42. PubMed ID: 16907851
[TBL] [Abstract][Full Text] [Related]
15. Long-term reversal of hypocholesterolaemia in patients with chronic hepatitis C is related to sustained viral response and viral genotype.
Fernández-Rodríguez CM; López-Serrano P; Alonso S; Gutiérrez ML; Lledó JL; Pérez-Calle JL; Temiño R; Cacho G; Nevado M; Casas ML; Gasalla JM; Bonet B
Aliment Pharmacol Ther; 2006 Aug; 24(3):507-12. PubMed ID: 16886916
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients.
Yoneda M; Saito S; Ikeda T; Fujita K; Mawatari H; Kirikoshi H; Inamori M; Nozaki Y; Akiyama T; Takahashi H; Abe Y; Kubota K; Iwasaki T; Terauchi Y; Togo S; Nakajima A
J Viral Hepat; 2007 Sep; 14(9):600-7. PubMed ID: 17697011
[TBL] [Abstract][Full Text] [Related]
17. HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice?
Jain A; Menegus M; Mohanka R; Orloff M; Abt P; Mantry P; Bozorgzadeh A
Exp Clin Transplant; 2006 Jun; 4(1):475-80. PubMed ID: 16827647
[TBL] [Abstract][Full Text] [Related]
18. Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection.
Ramos-Casals M; Forns X; Brito-Zerón P; Vargas A; Ruiz M; Laguno M; Yagüe J; Sánchez-Tapias JM; Gatell JM; Font J
J Viral Hepat; 2007 Oct; 14(10):736-42. PubMed ID: 17875009
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of intrahepatic HCV RNA level in chronic HCV infection].
Jang JY; Kim YS; Kim SG; Kim YS; Cho YD; Lee JS; Jin SY; Lee MS; Kim JH; Shim CS; Kim BS
Korean J Hepatol; 2006 Dec; 12(4):515-23. PubMed ID: 17237629
[TBL] [Abstract][Full Text] [Related]
20. Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment.
Gopal K; Johnson TC; Gopal S; Walfish A; Bang CT; Suwandhi P; Pena-Sahdala HN; Clain DJ; Bodenheimer HC; Min AD
Hepatology; 2006 Aug; 44(2):335-40. PubMed ID: 16871569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
